J. Barré

发表

Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans.

J. Barré, G. Houin, J. Tillement, 1984, Journal of pharmaceutical sciences.

Measurement of free drug in phase I: is it useful?

J. Barré, J. Tillement, P. Riant, 1990, Fundamental & clinical pharmacology.

Comparative Pharmacokinetics of Intravenous Propranolol in Obese and Normal Volunteers

J. Barré, G. Cheymol, J. Poirier, 1987, Journal of clinical pharmacology.

Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity.

D. Dhumeaux, J. Barré, G. Houin, 1987, British journal of clinical pharmacology.

Docetaxel serum protein binding with high affinity to alpha1-acid glycoprotein

S. Urien, J. Barré, J. Tillement, 2004, Investigational New Drugs.

Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution.

J. Barré, G. Houin, J. Tillement, 1989, Progress in clinical and biological research.

Clinical pharmacology of oxicams: new insights into the mechanisms of their dose-dependent toxicity.

P. Carrupt, B. Testa, P. Jolliet, 1993, International journal of tissue reactions.

Population pharmacokinetics of oral baclofen at steady‐state in alcoholic‐dependent adult patients

F. Bellivier, J. Barré, F. Thibaut, 2018, Fundamental & clinical pharmacology.

Expression of the genetic variants of human alpha-1-acid glycoprotein in cancer.

S. Urien, J. Barré, I. Monnet, 2000, Clinical biochemistry.

Effects of Plasma Lipid Levels on Blood Distribution and Pharmacokinetics of Cyclosporin A

J. Barré, J. Tillement, D. Loisance, 1993, Therapeutic drug monitoring.

Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.

J. Barré, G. Houin, J. Tillement, 1985, Clinical chemistry.

Influence of bile salts and lipids on intestinal absorption of griseofulvin in man

J. Barré, G. Houin, M. Rongier, 2004, European Journal of Clinical Pharmacology.

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer.

J. Dalphin, P. Bechtel, J. Barré, 1991, British journal of clinical pharmacology.

Pharmacokinetics of Intravenously Administered 125I-Labelled Human α1-Acid Glycoprotein

J. Barré, G. Houin, J. Tillement, 1986 .

Disease-Induced Variations in Plasma Protein Levels

J. Barré, J. Tillement, P. Riant, 1990 .

Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycop

J. Barré, J. Tillement, P. D'athis, 1996, Pharmacogenetics.

pH titration curves of the desialylated human alpha 1-acid glycoprotein variants by combined isoelectrofocusing-electrophoresis: utilization in the development of a fractionation method for the protein variants by chromatography on immobilized metal affinity adsorbent.

J. Barré, J. Tillement, M. Millot, 1992, Journal of chromatography.

Pharmacological criteria for risk-benefit evaluation of NSAIDs.

S. Urien, J. Barré, J. Tillement, 1988, Scandinavian journal of rheumatology. Supplement.

Dextromethorphan O-demethylation and dextrorphan glucuronidation in a French population.

J. Barré, J. Tillement, J. Duché, 1993, International journal of clinical pharmacology, therapy, and toxicology.

Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure

J. Barré, D. Tran, B. Oosterhuis, 2003, Biopharmaceutics & drug disposition.

Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences.

P. Jolliet, J. Barré, J. Tillement, 1998, International journal of clinical pharmacology and therapeutics.

In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.

J. Barré, G. Houin, J. Tillement, 1986, International journal of clinical pharmacology research.

[Value of cyclosporin A in dermatomyositis in a child].

J. Barré, J. Tillement, P. Reinert, 1988, Archives francaises de pediatrie.

Effect of erythrocytes and plasma protein binding on the transport of progabide and SL 75102 through the rat blood-brain barrier.

S. Urien, J. Barré, J. Tillement, 1987, Biochemical pharmacology.

The apparent volumes of distribution of H1 receptor antagonists

J. Barré, J. Tillement, E. Albengres, 2000 .

Effect of Ginkgo biloba extract on microsomal enzyme induction.

J. Barré, J. Tillement, P. Guinot, 1989, International journal of clinical pharmacology research.

Role of bilirubin in the regulation of the total peroxyl radical trapping antioxidant activity of plasma in sickle cell disease.

S. Urien, J. Barré, J. Tillement, 1998, Biochemical and biophysical research communications.

Glycosylation study of the major genetic variants of human alpha1-acid glycoprotein and of their pharmacokinetics in the rat.

J. Barré, J. Tillement, P. D'athis, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?

O. Baud, J. Barré, C. Alberti, 2010, PloS one.

The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance

B. Sébille, S. Urien, J. Barré, 1984 .

Evidence for a concentration-dependent polymerization of a commercial human serum albumin.

B. Sébille, J. Barré, J. Tillement, 1981, Journal of chromatography.

Increase in the vascular residence time of propranolol-loaded nanoparticles coated with heparin.

J. Barré, A. Lamprecht, P. Maincent, 2008, Journal of nanoscience and nanotechnology.

Disease-induced modifications of drug pharmacokinetics.

J. Barré, G. Houin, J. Tillement, 1983, International journal of clinical pharmacology research.

Pharmacokinetics of intravenously administered 125I-labelled human alpha 1-acid glycoprotein.

J. Barré, G. Houin, J. Tillement, 1986, Clinical pharmacokinetics.

Continuous epidural infusion of bupivacaine for postoperative pain relief in children.

C. Meistelman, J. Barré, C. Saint-Maurice, 1987, Anesthesiology.

Influence of aeration rate on transformations of separated pig manure and gaseous emissions during composting.

J. Barré, P. Neveu, C. Burton, 2009 .

Diclofenac binding to albumin and lipoproteins in human serum.

G Houin, S. Urien, J. Barré, 1985, Biochemical pharmacology.

Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin

J. Barré, E. Bingen, C. Doit, 1997, Antimicrobial agents and chemotherapy.

Problems in therapeutic drug monitoring: free drug level monitoring.

J. Barré, J. Tillement, F. Delion, 1988, Therapeutic drug monitoring.

Melatonin Levels in Preterm and Term Infants and Their Mothers

P. Gressens, V. Biran, O. Baud, 2019, International journal of molecular sciences.

Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime—a population study in 25 elderly patients

J. Barré, P. Maire, S. Urien, 2004, European Journal of Clinical Pharmacology.

Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal

J. Barré, R. Cohen, X. Durrmeyer, 2019, Front. Pediatr..

Protein binding of propisomide.

J. P. Jeanniot, J. Barré, G. Houin, 1985, Journal of pharmaceutical sciences.

Binding of indomethacin to human serum albumin. Its non displacement by various agents, influence of free fatty acids and the unexpected effect of indomethacin on warfarin binding.

J. Barré, J. Tillement, P. D'athis, 1979, Biochemical pharmacology.

A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: A double-site model for drug absorption

Yves Plusquellec, J. Barré, G. Houin, 1987, Journal of Pharmacokinetics and Biopharmaceutics.

Continuous Epidural Infusion of Bupivacaine for Postoperative Pain Relief in Children

C. Meistelman, J. Barré, C. Saint-Maurice, 1986 .

Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans

J H Proost, B Plaud, C. Meistelman, 1995, Clinical pharmacology and therapeutics.

Disease-Induced Variations in Plasma Protein Levels Implications for Drug Dosage Regimens (Part I)

J. Barré, J. Tillement, P. Riant, 1990, Clinical pharmacokinetics.

Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

J. Barré, J. Tillement, P. Riant, 1990, Clinical pharmacokinetics.

Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.

J. Barré, G. Houin, P. Jungers, 1986, Clinical nephrology.

Effects of age on plasma protein binding of sufentanil.

D. Benhamou, C. Meistelman, J. Barré, 1987, Anesthesiology.

Influence of food on the absorption of the p-chlorophenolic ester of chlorophenoxyisobutyric acid in man.

J. Barré, G. Houin, J. Tillement, 1984, British Journal of Clinical Pharmacology.

[Pharmacokinetic properties of cefixime].

J. Barré, 1989, Presse medicale.

In Vitro Binding and Partitioning of Irinotecan (CPT-11) and its Metabolite, SN-38, in Human Blood

Saïk Urien, Jérôme Barré, Olivier Combes, 2000, Investigational New Drugs.

The Significance of Plasma‐Protein Binding in Drug Research

Jérôme Barré, S. Urien, J. Barré, 2007 .

Rapid liquid chromatographic determination of debrisoquine and its hydroxy metabolite in human urine to define hydroxylation phenotypes.

J. Barré, J. Tillement, J. Duché, 1987, Journal of chromatography.

Binding studies of macrolides, lincosamides and streptogramins to Streptococcus G group using [3H]-erythromycin.

J. Barré, J. Tillement, L. Deforges, 1987, Biochemical Pharmacology.

Binding parameters and microbiological activity of macrolides, lincosamides and streptogramins against Staphylococcus aureus

J. Duval, J. Barré, L. Deforges, 1987, The Journal of pharmacy and pharmacology.

In vitro [3H]-erythromycin binding to Staphylococcus aureus.

J. Duval, J. Barré, J. Tillement, 1986, Biochemical pharmacology.

Comparison of Propranolol and Sotalol Pharmacokinetics in Obese Subjects

J. Barré, G. Cheymol, J. Poirier, 1990, The Journal of pharmacy and pharmacology.

Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding.

D. Dhumeaux, J. Barré, G. Houin, 1984, British journal of clinical pharmacology.

Plasma and tissue binding as determinants of drug body distribution. Possible applications to toxicological studies.

S. Urien, J. Barré, J. Tillement, 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[Respective role of mifepristone (RU486) binding to blood and tissue proteins in its quantitative distribution in the body].

J. Barré, J. Tillement, B. Grimaldi, 1992, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Absolute intramuscular, oral, and rectal bioavailability of alizapride.

J. Barré, G. Houin, J. Tillement, 1984, Journal of pharmaceutical sciences.

Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administration.

J. Barré, G. Houin, J. Tillement, 1992, Journal of pharmaceutical sciences.

Food increases the bioavailability of mefloquine

J. Barré, D. Roumenov, C. Crevoisier, 1997, European Journal of Clinical Pharmacology.

Methylprednisolone infusion during acute exacerbation of MS: plasma and CSF concentrations.

J. Degos, J. Barré, J. Tillement, 1995, European neurology.

Bioavailability of a Co-formulated Combination of Amodiaquine and Artesunate under Fed and Fasted Conditions

J. Barré, S. Fitoussi, A. Filali-Ansary, 2009, Arzneimittelforschung.

Stealth nanoparticles coated with heparin as peptide or protein carriers

J. Barré, C. Passirani, T. Lecompte, 2009, Journal of drug targeting.

BLOOD BINDING AND TISSUE UPTAKE OF DRUGS. RECENT ADVANCES AND PERSPECTIVES

S. Urien, J. Barré, J. Tillement, 1988 .

BLOOD BINDING AND TISSUE UPTAKE OF DRUGS. RECENT ADVANCES AND PERSPECTIVES

S. Urien, J. Barré, J. Tillement, 1988, Fundamental & clinical pharmacology.

Comment on: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

J. Barré, P. Lechat, S. Mouly, 2019, Clinical Pharmacokinetics.

Binding of erythromycin base to human plasma proteins.

J. Barré, J. Tillement, P. D'athis, 1980, The Journal of international medical research.

Pharmacokinetics of Tenatoprazole, a Newly Synthesized Proton Pump Inhibitor, in Healthy Male Caucasian Volunteers

J. Barré, G. Houin, H. Ficheux, 2006, Arzneimittelforschung.

Acute haemodynamic effects and tissue distribution of acebutolol in normotensive and spontaneously hypertensive rats.

J. Barré, F. Beslot, J. Wepierre, 1985, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.